Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership
2021-05-27 08:30
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services
2021-05-14 08:30
WuXi Biologics Completed Three Acquisitions to Enhance its Global Network
2021-05-07 08:30
WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC
2021-04-13 17:00
WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA
2021-04-07 08:22
2020 Results Record High Despite a Challenging Year
2021-03-23 20:59
WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group
2021-03-18 08:59
WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China
2021-03-17 08:45
WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19
2021-03-16 16:30
Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility
2021-03-03 18:23
WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories
2021-02-25 08:00
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics
2021-02-09 08:25
WuXi Biologics Receives GMP Certification from Brazil's ANVISA
2020-12-28 17:50
WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer
2020-12-21 21:02
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation
2020-12-02 19:00
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou
2020-11-20 16:30
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa
2020-10-29 17:00
Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines
2020-10-15 08:59
WuXi Biologics Records Excellent Interim Results
2020-08-18 00:51
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer
2020-08-06 17:00
1
2
3
4
5
6
9